Exosomal ORF3a mediates lung-liver axis to dysregulate hepatic lipid metabolism in mild COVID-19.

Publication date: May 23, 2026

Open Access PDF

Concepts Keywords
Covid Axis
Genes Covid
Hepatic Discov
Liver Dysregulate
Exosomal
Genes
Hepatic
Lipid
Liver
Lung
Mediates
Metabolism
Mild
Proteins

Semantics

Type Source Name
disease MESH COVID-19
disease MESH severe acute respiratory syndrome
disease MESH infection
disease MESH included
disease MESH ALP
disease MESH liver dysfunction
disease MESH strain
pathway KEGG Lysosome
disease MESH liver fibrosis
pathway REACTOME Metabolism
pathway KEGG Viral replication
disease MESH inflammation
disease MESH cytokine storm
drug DRUGBANK Coenzyme M
disease MESH SCD
drug DRUGBANK Trestolone
drug DRUGBANK Hydroxyproline
disease MESH nonalcoholic fatty liver disease
drug DRUGBANK Dimethyl sulfoxide
drug DRUGBANK Proline
pathway REACTOME Apoptosis
disease MESH Infectious Diseases
disease MESH Respiratory Diseases
disease MESH Emergency
disease MESH ccf
disease MESH Park
pathway REACTOME Reproduction

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *